Alexa… What’s the deal with voice assistants?
As the buzz around voice technology increases, our digital team is asked more & more, “What’s the deal with voice assistants? Can we offer this to our clients?”
The Long Journey towards Patient Centricity
Various regulatory efforts have been implemented in the last 25-30 years to include the patients’ perspective into drug development.
Insights from Inside the Jury Room: 2019 Medical, Marketing & Media (MM&M) Awards
Read our latest blog post to access insights from inside the 2019 Medical Marketing & Media (MM&M) Awards jury room.
Patient Centricity in Oncology Trials
Adopting patient-centric elements into oncology clinical trials has the potential to significantly impact patient recruitment and retention.
Pharma Marketing in the Digital Age
Social media and digital technology are providing new opportunities for marketers by facilitating direct interaction with patients and care partners.
Connecting with the Patient for Better Insights
Getting more connected with the patient and easing their burden is really making a difference to enrollment rates.
The Need for New Business Models under MDR/IVDR
The new MDR/IVDR will go into effect in 2020, greatly increasing the complexity of keeping existing products on the market and introducing new ones.
5 Applications of AI to Enhance RWE Generation
Exploring machine learning and natural language processing to maximize RWE output using advanced computing.
EMA Publishes Second Draft Guideline on New MDR Rules Specifying Quality Requirements for Drug-Device Combinations
Key takeaways from the EMA’s second draft guidance on MDR and its impact on combination products.
Tackling RWE Challenges to Demonstrate Healthcare Value
Despite multiple challenges, RWE clearly has huge potential to inform healthcare stakeholders.
Towards a Data-Driven Feasibility Assessment
Explore how conducting a thorough data-driven feasibility assessment sets sponsors up for success in the operational aspects of their trials.
The Digitization of Clinical Drug Development
ICON expert Dr. Uma Arumugam takes a look at the advancements in digital applications and technology impacting clinical drug development.
Biosimilar Development in Ophthalmology
ICON experts Bart Chapman and Shanthi Sundaramoorthy answer common questions about ophthalmology studies, and those relating to biosimilars.
Using Economic Models to Gain Early Access
Early access schemes demand new ways of performing health economic evaluations.
How Value-Based Healthcare affects Medical Device Development
Manufacturers need to employ new methods and tools to maximise the effectiveness of their efforts in bringing new devices to market.
5 Common Barriers to Harmonised Real World Data
Learn 5 common barriers to Real World Data (RWD) harmonisation and insights on how to overcome these challenges.
ePharma IMPACT 2019 Recap
ICON's Travis Tingey attended the recent ePharma IMPACT conference and shares his thoughts on notable trends and themes.
Reflections from MAPS Conference 2019
ICON Medical Communications attended the 2019 MAPS Annual Meeting and share key themes and trends.
AMCP Annual Meeting 2019 Recap
Key topics and trends covered at the AMCP 2019 Annual Meeting.
Accelerating Drug Development for Patients with Rare Diseases
CROs can help to create more patient-centric trials placing the patients’ needs and day to day life as the highest priority in protocol and operational design.